Weiss on How Nanoparticles are Enhancing Radiation Therapy in Lung Cancer

JNJ-1900 (NBTXR3), a novel radioenhancer, shows promises as an innovative approach to enhance local tumor control without escalating systemic toxicity across solid tumors, including lung cancer, according to preliminary findings from an ongoing phase 1 …

Use of Broad Genomic Profiling for Cancer Still Suboptimal

TOPLINE: Broad genomic profiling was used in only 1 in 4 US patients with newly diagnosed metastatic cancer between 2020 and 2022, a new study reported. Although testing rates increased over this time period, they remained under 50%, even in cases where …

Sharmila Tagore Lung Cancer: Everything You Need To Know About Zero-Stage Lung Cancer

Veteran actor Sharmila Tagore revealed that she had quietly battled cancer in 2023. The news took many fans by surprise, not only because of the disclosure itself but also due to how minimal her treatment had been. Her daughter, Soha Ali Khan, explained …

AI can pick up signs of lung cancer quicker than doctors: study

Artificial Intelligence can detect signs of lung cancer up to four months more quickly than family doctors, a study by researchers at Amsterdam’s UMC teaching hospital has shown. The researchers developed an AI-based model which analysed doctors’ notes of …

Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small ...

CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that results from the REZILIENT1 study of zipalertinib …

AI helps GPs detect lung cancer 4 months earlier

Now many patients are diagnosed with lung cancer in an advanced stage, 3 or 4, which means that 80% of patients often die within a year. [...] Receiving a diagnosis four weeks earlier [...] is therefore probably a very relevant gain Henk van Weert The …

Treatment De-escalation in Lung Cancer

Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of cumulative and long-term treatment toxicities. But could patients …

UK Funds AI Blood Test for Early Cancer Detection

A clinical trial of a promising blood test that could offer faster and more accurate diagnoses for common cancers has received funding from the Department of Health and Social Care (DHSC). The miONCO-Dx test detects cancer at an early stage by analysing …

Pioneering cancer studies to use NHS patient data from the region

The studies, which include research into aggressive bladder cancer and early diagnosis of lung cancer, will use the new Wessex Secure Data Environment (SDE). This is a secure platform for storing and linking NHS patient data, led by University Hospital …

Akeso reports another Phase 3 win for PD-1xVEGF approach in lung cancer